Eye medicine for preventing and treating asthenopia and allergy

A technology for eye fatigue and allergy, which is applied in the preparation of medicines for preventing and treating eye fatigue and allergy, and the field of compound preparations for treating and preventing eye fatigue and allergy, which can solve problems such as the inability to play an anti-eye fatigue effect and the like.

Inactive Publication Date: 2006-10-04
崔彬
View PDF0 Cites 11 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, various drugs alone cannot

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0013] Take 2g of taurine, 0.02g of naphazoline hydrochloride, vitamin B 6 Add 0.01g, 0.4g of chlorpheniramine maleate, 0.5g of sodium hyaluronate, 1g of borax, and 0.17g of boric acid into 100ml of water for injection, dissolve, and mix well to obtain eye drops for eye fatigue and allergy.

Embodiment 2

[0015] Take 2g of taurine, 0.01g of naphazoline hydrochloride, vitamin B 6 Add 0.02g, 0.3g of chlorpheniramine maleate, 0.5g of sodium hyaluronate, 0.3g of menthol, 1g of borax, and 0.17g of boric acid into 100ml of water for injection, dissolve and mix well to obtain eye drops for eye fatigue and allergy agent.

Embodiment 3

[0017] Take 2g of taurine, 0.01g of naphazoline hydrochloride, vitamin B 6 Add 0.02g, 0.3g of chlorpheniramine maleate, 0.5g of sodium hyaluronate, 0.3g of menthol, 1g of borax, 0.17g of boric acid, 5ml of glycerin, add 100ml of water for injection, dissolve, and mix well to obtain anti-eye fatigue and Allergy eye drops.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

Disclosed is a compound preparation for treating and preventing eye strain and allergy, which comprises (by weight percent) taurine 0.1-99.9%, naphazoline hydrochloride 0.01-99.9%, vitamin B6 0.01-99.9%, chlorpheniramine maleate 0.01-99.9%, and right amount of auxiliary therapeutic medicaments such as menthol, sodium hyaluronate, glycerine and medicinal findings such as preservative agent and buffering agent.

Description

Technical field: [0001] The present invention relates to a kind of preparation with taurine, naphazoline hydrochloride, vitamin B 6 , chlorpheniramine maleate and other four kinds of medicines are the compound preparations for treating and preventing eye fatigue and allergies. And the application of various preparations obtained by the method of the present invention in the field of pharmacy, especially the application in the preparation of medicines for preventing and treating eye fatigue and allergy. The medicine of the present invention has clear primary and secondary prescriptions, proper compatibility, complementary and mutual promotion. Background technique: [0002] Eye fatigue is caused by eye discomfort after continuous close work, pain in or around the eyeball, soreness at the root of the nose, blurred vision, dry eyes, pressure, sensitivity to light, double vision and tearing, dizziness, nausea, vomiting Night sweats, pale complexion, slow movement, neck muscle ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/4415A61K31/4164A61K31/185A61K31/4402A61P27/02
Inventor 姜淑琴
Owner 崔彬
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products